CD40 and neoplasm: We therefore sought to enhance the tumor-killing activity of DC-CIK cells in two distinct ways: First, by promoting maturation and activation of antigen-presenting DCs through CD40 ligation, and second, by suppressing inhibitory signaling in the effector cells or reducing Tregs by CTLA-4 blockade.